Loading...
•
Sep 30, 2023
Pediatrix Q3 2023 Earnings Report
Pediatrix reported earnings of $0.26 per share and Adjusted EPS of $0.32 for the third quarter of 2023.
Key Takeaways
Pediatrix Medical Group reported net revenue of $507 million and income from continuing operations of $21 million, or $0.26 per share, for the three months ended September 30, 2023. Adjusted EPS from continuing operations was $0.32. The company anticipates its 2023 Adjusted EBITDA to be in the range of $200 million to $210 million.
Net revenue for the third quarter was $507 million, compared to $489.9 million for the prior-year period.
Income from continuing operations was $21 million, or $0.26 per diluted share.
Adjusted EBITDA was $50 million.
Overall same-unit revenue increased by 4.1 percent.
Forward Guidance
Pediatrix anticipates that its 2023 Adjusted EBITDA will be in a range of $200 million to $210 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...